457947-61-4

Basic information

• Product Name: Benzoic acid, 4-amino-5-chloro-2-methoxy-3-nitro-, methyl ester
• CAS NO: 457947-61-4
• Molecular Formula: C9H9ClN2O5
• Molecular Weight: 260.634
• Mol File: 457947-61-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-amino-5-chloro-2-methoxy-3-nitro-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-amino-5-chloro-2-methoxy-3-nitro-, methyl ester(457947-61-4)
• EPA Substance Registry System: Benzoic acid, 4-amino-5-chloro-2-methoxy-3-nitro-, methyl ester(457947-61-4)

Safety Data

• Hazardous Substances Data: 457947-61-4(Hazardous Substances Data)

Upstream product

• 20896-27-9 methyl 4-amino-5-chloro-2-methoxybenzoate 
• 126463-85-2 4-acetylamino-5-chloro-2-methoxy-3-nitro-benzoic acid methyl ester 
• 4093-31-6 methyl 2-methoxy 4-acetamido 5-chloro benzoate 

Downstream Products

• 1312608-71-1 C₄₂H₅₁N₉O₇ 
• 1312610-74-4 C₃₈H₄₅N₇O₅ 
• 1312610-73-3 C₃₆H₄₅N₇O₅ 
• 1312610-72-2 C₃₆H₄₂ClN₇O₇ 
• 1312610-71-1 C₃₇H₄₄ClN₇O₇ 
• 1312610-70-0 C₃₇H₄₄ClN₃O₁₃ 
• 1312610-62-0 C₄₃H₄₈ClN₃O₁₃ 
• 1312610-61-9 C₂₃H₁₆Br₂ClNO₅ 
• 1312611-72-5 C₂₁H₁₂Cl₃NO₅ 
• 1312610-60-8 C₂₁H₁₄ClNO₇ 
• 1312610-59-5 C₂₃H₁₈ClNO₇ 
• 1312610-56-2 C₉H₇BrClNO₅ 
• 1279088-66-2 (1-{4-[6-oxo-8-phenyl-1-(2-trimethylsilanyl-ethoxymethyl)-1,6-dihydro-chromeno[7,8-d]imidazol-7-yl]-phenyl}-cyclobutyl)-carbamic acid tert-butyl ester 
• 1279088-67-3 (1-{4-[6-oxo-8-phenyl-3-(2-trimethylsilanyl-ethoxymethyl)-3,6-dihydro-chromeno[7,8-d]imidazol-7-yl]-phenyl}-cyclobutyl)-carbamic acid tert-butyl ester 

Relevant articles and documents

As neuroprotective agents of pharmaceutical compounds

The invention discloses a medicinal compound as a neuroprotective agent. The medicinal compound is a neuronal nitric oxide synthase-postsynaptic density protein 95 (nNOS-PSD95) decoupling agent. The medicinal compound is a benzene ring derivative shown in the general formula (I) or its pharmaceutically acceptable salt. The invention further discloses a preparation method of the medicinal compound and a use of the medicinal compound in prevention and treatment on neuronal damage influence-caused diseases.

ORGANIC COMPOUNDS

Compounds of formula (I) in free or salt form, where Y, R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the CXCR2 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.

NITROGEN-CONTAINING HETEROARYL COMPOUNDS HAVING HIV INTEGRASE INHIBITORY ACTIVITY

A compound of the formula (I): wherein Z4, Z5 and Z9 each is independently carbon atom or nitrogen atom; Y is hydroxy, mercapto or amino; RA is a group of the formula: (wherein C ring is nitrogen-containing heteroaryl) has an inhibitory activity against integrase.